Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Press release.pdfPress release
  2. Q1 2026 Unaudited Interim Report of the Krka Group and Krka Company.pdfQ1 2026 Unaudited Interim Report of the Krka Group and Krka Company

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 25 / 2026
Date of issue: 2026-05-14
Short name of the issuer
KRKA
Subject
Unaudited Interim Report of the Krka Group and the Krka, d. d., Novo mesto for the first quarter of 2026
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Based on Article 26 of the Rules of the Ljubljana Stock Exchange, the company Krka, d. d., Novo mesto publishes the Unaudited interim Report of the Krka Group and Krka, d. d., Novo mesto for the first quarter of 2026.

The report will be published on the Company's website (www.krka.biz) from 14 May 2026 onwards, for a minimum period of 5 years.
Annexes
File Description
Press release.pdf
Press release.pdf		 Press release
Q1 2026 Unaudited Interim Report of the Krka Group and Krka Company.pdf
Q1 2026 Unaudited Interim Report of the Krka Group and Krka Company.pdf		 Q1 2026 Unaudited Interim Report of the Krka Group and Krka Company

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-05-14 Jože Colarič President of the Management Board and CEO
20260514_082231_1865969265_Press_release.pdf

Pobierz
20260514_082231_1865969265_Q1_2026_Unaudited_Interim_Report_of_the_Krka_Group_and_Krka_Company.pdf

Pobierz